{"id":56972,"date":"2024-02-27T17:16:42","date_gmt":"2024-02-27T17:16:42","guid":{"rendered":"https:\/\/medsname.com\/ezedoc\/"},"modified":"2026-05-01T10:49:13","modified_gmt":"2026-05-01T10:49:13","slug":"ezedoc","status":"publish","type":"product","link":"https:\/\/medsbase.com\/sv\/product\/ezedoc\/","title":{"rendered":"Ezedoc"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Ezedoc?<\/h3>\n<p style=\"margin:0;\"><strong>Ezedoc<\/strong> inneh\u00e5ller <strong>ezetimibe<\/strong> (10 mg), en <strong>cholesterol-absorption inhibitor<\/strong> that blocks the NPC1L1 transporter in the small intestine. It is the <strong>go-to add-on therapy when a statin alone doesn&rsquo;t get LDL to target<\/strong>. On its own, ezetimibe lowers LDL-C by about 17&ndash;22%. Added to a statin, it produces an additional ~20&ndash;25% LDL reduction, totaling a 55&ndash;60% fall &mdash; equivalent to doubling the statin dose without the dose-related muscle or liver side effects. The <strong>IMPROVE-IT<\/strong> trial (18,144 patients post-ACS) proved that adding ezetimibe to simvastatin further reduces cardiovascular events. Dose: 10&nbsp;mg once daily, any time, with or without food. Generally very well-tolerated &mdash; mild GI upset, occasional myalgia, rare transaminase elevation. Avoid in severe hepatic impairment.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Vad du f\u00e5r med MedsBase:<\/strong> WHO-GMP-certifierad tillverkare \u00b7 Diskret f\u00f6rpackning \u00b7 V\u00e4rldsvid leverans \u00b7 1 400+ verifierade <a href=\"https:\/\/medsbase.com\/sv\/reviews\/\">kundrecensioner<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Varje best\u00e4llning omfattas av v\u00e5r <a href=\"https:\/\/medsbase.com\/sv\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 om din f\u00f6rs\u00e4ndelse inte anl\u00e4nder inom 20 arbetsdagar, skickar vi om den.<\/p>\n<h3>Varf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n<p>V\u00e5ra generiska l\u00e4kemedel kommer fr\u00e5n WHO-GMP-certifierade tillverkare och skickas v\u00e4rldsvidt i diskreta, enkla f\u00f6rpackningar \u2014 inget l\u00e4kemedelsnamn p\u00e5 f\u00f6rs\u00e4ndelsens utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdrag visar en reglerad kortbetalningsprocessor \u2014 aldrig \u201cMedsBase\u201d eller n\u00e5got l\u00e4kemedelsnamn). Krypto och SEPA-bank\u00f6verf\u00f6ring accepteras ocks\u00e5. Varje best\u00e4llning backas upp av v\u00e5r Reshipment Assurance Policy.<\/p>\n<h2 class=\"wp-block-heading\">What Is Ezedoc?<\/h2>\n<p>Ezedoc is an oral lipid-lowering medicine containing <strong>ezetimibe<\/strong> (10 mg), manufactured by WHO-GMP certified manufacturer. Supplied in packs of 30, 60, 90 or 180 tablets. Ezetimibe is the first and only drug of the <strong>cholesterol-absorption inhibitor<\/strong> class. Originator brand: <strong>Zetia \/ Ezetrol<\/strong> (Merck, 2002).<\/p>\n<p>Ezetimibe is a mainstay of second-line lipid management &mdash; the first choice when you need more LDL reduction than a tolerated statin dose provides, or when a patient cannot tolerate higher statin doses. It is also the most common partner in fixed-dose combinations (simvastatin\/ezetimibe = Inegy\/Vytorin; rosuvastatin\/ezetimibe = various).<\/p>\n<h2 class=\"wp-block-heading\">What Is Ezedoc Used For?<\/h2>\n<ul>\n<li><strong>Prim\u00e4r hyperkolesterolemi<\/strong> &mdash; as add-on to a statin when LDL is not at goal on the maximum tolerated statin dose<\/li>\n<li><strong>Statin intolerance<\/strong> &mdash; as monotherapy or with a very low statin dose when a full statin dose causes muscle or liver problems<\/li>\n<li><strong>Familj\u00e4r hyperkolesterolemi<\/strong> (heterozygous and homozygous) &mdash; in combination with statin<\/li>\n<li><strong>Secondary prevention after acute coronary syndrome<\/strong> &mdash; add to statin to further reduce CV events (IMPROVE-IT trial)<\/li>\n<li><strong>Sitosterolaemia<\/strong> &mdash; a rare genetic condition where ezetimibe is disease-modifying<\/li>\n<\/ul>\n<p>Ezetimibe is weak as a monotherapy (~17% LDL reduction) compared to a statin (~30&ndash;60%); it is most powerful as an add-on.<\/p>\n<h2 class=\"wp-block-heading\">How Does Ezedoc Work?<\/h2>\n<p>Ezetimibe selectively inhibits the <strong>Niemann-Pick C1-Like 1 (NPC1L1) transporter<\/strong> on enterocytes in the proximal small intestine. NPC1L1 is responsible for absorbing dietary and biliary cholesterol from the gut lumen into the enterocyte.<\/p>\n<p>With NPC1L1 blocked:<\/p>\n<ul>\n<li><strong>Intestinal cholesterol absorption falls by ~54%<\/strong><\/li>\n<li><strong>Hepatic cholesterol stores decrease<\/strong> because less cholesterol reaches the liver<\/li>\n<li><strong>LDL receptors are upregulated<\/strong> on hepatocytes &mdash; the liver pulls more LDL out of the blood<\/li>\n<li><strong>Plasma LDL-C falls by 17&ndash;22%<\/strong> as monotherapy; up to 25% additional when combined with a statin<\/li>\n<li>HMG-CoA reductase activity (the statin target) is unchanged<\/li>\n<\/ul>\n<p>Because ezetimibe and statins act on <strong>complementary pathways<\/strong> (absorption vs synthesis), their effects are additive. Statins reduce LDL synthesis; ezetimibe reduces LDL absorption\/input. Together they drop LDL more than either can alone, without adding to each other&rsquo;s side-effect profile.<\/p>\n<p>Outcome data: the <strong>IMPROVE-IT trial<\/strong> (2015) showed adding ezetimibe to simvastatin in post-ACS patients reduced the composite CV endpoint by 6.4% (NNT 50 over 7 years), confirming that the LDL-lowering translates into real event reduction.<\/p>\n<h2 class=\"wp-block-heading\">Dosering och administration<\/h2>\n<p><strong>Standarddos:<\/strong> 10&nbsp;mg once daily at any time of day, with or without food.<\/p>\n<ul>\n<li>Take at a consistent time for adherence.<\/li>\n<li>Can be taken at the same time as a statin or spaced out &mdash; no timing interaction.<\/li>\n<li>Miss a dose &mdash; take it as soon as you remember unless close to the next; do not double up.<\/li>\n<li>No dose adjustment needed for renal impairment or mild-to-moderate hepatic impairment.<\/li>\n<li>Monitor lipid panel and ALT at baseline and 6&ndash;8 weeks after starting. Check CK only if symptoms.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Biverkningar<\/h2>\n<p>Ezetimibe is one of the best-tolerated lipid-lowering drugs. Adverse events are close to placebo rates in trials.<\/p>\n<p><strong>Common (&lt; 5%):<\/strong><\/p>\n<ul>\n<li>Mild diarrhoea, flatulence<\/li>\n<li>Upper respiratory tract infection, sinusitis<\/li>\n<li>Tr\u00f6tthet<\/li>\n<li>Arthralgia<\/li>\n<\/ul>\n<p><strong>Ovanliga:<\/strong><\/p>\n<ul>\n<li>Transaminase elevation &mdash; usually small; more common when combined with a statin<\/li>\n<li>Muscle pain, myalgia, myopathy &mdash; rare; primarily when combined with statin<\/li>\n<li>Hypersensitivity, angioedema, rash<\/li>\n<li>Pancreatitis &mdash; very rare<\/li>\n<li>Cholelithiasis &mdash; very rare<\/li>\n<li>Thrombocytopenia &mdash; very rare<\/li>\n<li>Rhabdomyolysis &mdash; exceedingly rare, almost always in combination with a statin<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">L\u00e4kemedelsinteraktioner<\/h2>\n<ul>\n<li><strong>Cyclosporin<\/strong> &mdash; significantly raises ezetimibe levels (and vice versa). Monitor cyclosporine levels; some guidance suggests avoiding.<\/li>\n<li><strong>Bile acid sequestrants<\/strong> (cholestyramine, colestipol) &mdash; reduce ezetimibe absorption; take ezetimibe at least 2 hours before or 4 hours after.<\/li>\n<li><strong>Warfarin<\/strong> &mdash; occasional INR change reported; monitor when starting.<\/li>\n<li><strong>Statiner<\/strong> &mdash; no adverse PK interaction; this combination is the therapeutic mainstay.<\/li>\n<li><strong>Fibrates<\/strong> &mdash; fenofibrate\/ezetimibe combination is safe; gemfibrozil raises ezetimibe levels and is generally avoided.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Who Should Not Take Ezedoc?<\/h2>\n<ul>\n<li>Moderate-to-severe hepatic impairment (when combined with a statin)<\/li>\n<li>Active liver disease or persistent transaminase elevation &gt; 3&times; ULN<\/li>\n<li>Pregnancy (when combined with a statin)<\/li>\n<li>Amning<\/li>\n<li>Children &lt; 10 years (insufficient data)<\/li>\n<li>Known hypersensitivity to ezetimibe<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">F\u00f6rvaring<\/h2>\n<p>Store Ezedoc below 25&deg;C in a dry place, in the original blister. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Vanliga fr\u00e5gor<\/h2>\n<h3 class=\"wp-block-heading\">Can I take Ezedoc instead of a statin?<\/h3>\n<p>Usually no. As monotherapy, ezetimibe lowers LDL by only ~17% &mdash; much less than a statin (30&ndash;60%). It is appropriate as monotherapy only for patients who cannot tolerate any statin at any dose. For most people, the best lipid-lowering strategy is statin first, ezetimibe added if LDL is still above target.<\/p>\n<h3 class=\"wp-block-heading\">How does Ezedoc compare to doubling my statin dose?<\/h3>\n<p>Doubling a statin dose typically adds ~6% LDL reduction (the statin &ldquo;rule of 6&rdquo;). Adding ezetimibe adds ~20&ndash;25% LDL reduction. <strong>Adding ezetimibe is 3&ndash;4&times; more effective<\/strong> than doubling the statin, and without the dose-related rise in muscle symptoms. This is why modern guidelines favour statin + ezetimibe combination over pushing statin to maximum dose.<\/p>\n<h3 class=\"wp-block-heading\">Does Ezedoc reduce heart attacks and strokes?<\/h3>\n<p>Yes &mdash; the IMPROVE-IT trial (18,144 post-ACS patients) showed adding ezetimibe to simvastatin reduced the composite endpoint of CV death, MI, unstable angina, revascularisation, or stroke by 6.4% over 7 years. This is the landmark evidence that LDL reduction beyond statins alone still translates into real cardiovascular benefit.<\/p>\n<h3 class=\"wp-block-heading\">When should I take Ezedoc?<\/h3>\n<p>Any time of day is fine. Unlike simvastatin (evening preferred), ezetimibe timing is not dose-dependent &mdash; pick a time you will remember consistently. Many patients take it at the same time as their statin.<\/p>\n<h3 class=\"wp-block-heading\">Does Ezedoc cause muscle pain like statins?<\/h3>\n<p>Rarely. Ezetimibe monotherapy shows placebo-level muscle side effects. When combined with a statin, it does not meaningfully increase statin-related muscle symptoms compared with the statin alone.<\/p>\n<h3 class=\"wp-block-heading\">Where can I buy Ezedoc online?<\/h3>\n<p>You can order Ezedoc (10 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n<h2 class=\"wp-block-heading\">Relaterade kolesterolmediciner<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/sv\/lipvas\/\">Lipvas \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/crestor\/\">Crestor \u2014 Rosuvastatin 5\/10\/20 mg (AstraZeneca)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/rosuline\/\">Rosuline \u2014 Rosuvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/atorvatin\/\">Atorvatin \u2014 Atorvastatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/pivasta\/\">Pivasta \u2014 Pitavastatin (interaktionsfri)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/lipicard\/\">Lipicard \u2014 Fenofibrat (f\u00f6r triglycerider)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/high-cholesterol-treatments\/\"><strong>Bl\u00e4ddra bland alla mediciner mot h\u00f6gt kolesterol<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Medicinsk ansvarsfriskrivning.<\/strong> This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Unexplained muscle pain, yellowing of skin or eyes, or severe abdominal pain warrants prompt medical evaluation.<\/div>\n<h3 class=\"wp-block-heading\">Varf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n<p>Ezedoc is supplied through a WHO-GMP certified manufacturer with full COA documentation. We ship worldwide in plain, discreet packaging, and every order is covered by our <a href=\"\/sv\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>. Din betalningsbeskrivning vid kortbetalning visar den reglerade betalningsprocessorn (en reglerad kortbetalningsprocessor), aldrig \u201cMedsBase\u201d eller n\u00e5got medicinnamn.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterade alternativ<\/h3>\n<p>Andra produkter inom <strong>Kroniska tillst\u00e5nd<\/strong> som kunder \u00e4ven tittar p\u00e5:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/sv\/bencid\/\">Bencid<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/tiova-rotacaps\/\">Tiova Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/serobid-rotacaps\/\">Serobid Rotacaps<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/headset\/\">Headset<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/sv\/xafinact\/\">Xafinact<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Lowers Cholesterol Levels<br \/>\n\u2705 Minskar Risk f\u00f6r Hj\u00e4rtsjukdom<br \/>\n\u2705 Prevents Atherosclerosis<br \/>\n\u2705 Prescribed by Doctors<br \/>\n\u2705 Alternativ f\u00f6r oral medicinering<\/p>\n<p>Ezedoc contains Ezetimibe.<\/p>","protected":false},"featured_media":56973,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3953],"product_tag":[4210,4211],"class_list":{"0":"post-56972","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-high-cholesterol-treatments","9":"product_tag-ezedoc","10":"product_tag-ezetimibe","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product\/56972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/comments?post=56972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media\/56973"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/media?parent=56972"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_brand?post=56972"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_cat?post=56972"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_tag?post=56972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}